Insiders · Profile

Arix Bioscience plc

10% owner at Enliven Therapeutics. Filing since 16 Mar 2020. CIK 0001700449

Company

Date

Role

Action

Shares

Amount

Of holding

ELVN Enliven Therapeutics, Inc.

16 Mar 2020

10% owner

Bought

187,500

$3.00M

13.7%

1 decision on file.